Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • AI Disclosure
  • Shop

Finance

Ocugen
Finance

Ocugen Advances Gene Therapy Pipeline as Phase 3 Trials Near Key Milestones

November 12, 2025November 11, 2025 - by Timothy Alexander

MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) reported third-quarter 2025 financial results and provided an update on its advancing portfolio of late-stage gene therapies for inherited retinal diseases. The biotechnology …

Ocugen Advances Gene Therapy Pipeline as Phase 3 Trials Near Key Milestones Read More

TELA Bio
Finance

TELA Bio to Announce Q3 2025 Results, Host Investor Call November 13

November 11, 2025November 10, 2025 - by Timothy Alexander

MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced it will release its third-quarter 2025 financial results on Thursday, November 13, 2025, followed by a conference call and webcast at …

TELA Bio to Announce Q3 2025 Results, Host Investor Call November 13 Read More
Neuronetics, Inc
Finance

Neuronetics Sees Strong Growth and Leadership Shift as Integration Gains Momentum

November 11, 2025November 10, 2025 - by Timothy Alexander

MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) reported significant third-quarter gains, driven by the successful integration of Greenbrook TMS and expanding adoption of its NeuroStar Advanced Therapy System. The company …

Neuronetics Sees Strong Growth and Leadership Shift as Integration Gains Momentum Read More

Vishay Precision Group
Executives / Finance

Vishay Precision Group Delivers Strong Q3 Earnings and Expands Leadership Team

November 11, 2025November 10, 2025 - by Timothy Alexander

MALVERN, PA — Vishay Precision Group, Inc. (NYSE: VPG) reported solid third-quarter fiscal 2025 results, posting higher revenue, improved margins, and stronger profitability, supported by disciplined operations and strategic cost …

Vishay Precision Group Delivers Strong Q3 Earnings and Expands Leadership Team Read More
Palvella Therapeutics
Finance

Palvella Therapeutics to Report Q3 Results, Highlight Progress in Rare Skin Disease Trials

November 10, 2025November 10, 2025 - by Timothy Alexander

WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) announced it will report third-quarter 2025 financial results before markets open on Tuesday, November 11, 2025. Company leadership will host a live …

Palvella Therapeutics to Report Q3 Results, Highlight Progress in Rare Skin Disease Trials Read More

AMETEK
Finance

AMETEK Breaks Records With Double-Digit Growth and Upbeat 2025 Outlook

November 9, 2025November 5, 2025 - by Timothy Alexander

BERWYN, PA — AMETEK, Inc. (NYSE: AME) reported record financial results for the third quarter of 2025, driven by robust demand across its core business segments and continued execution of …

AMETEK Breaks Records With Double-Digit Growth and Upbeat 2025 Outlook Read More
First Resource Bancorp, Inc
Finance

First Resource Bank Sets Records as Margin Climbs and Assets Top $700 Million

November 8, 2025November 5, 2025 - by Timothy Alexander

EXTON, PA — First Resource Bancorp, Inc. (OTCQX: FRSB), parent of First Resource Bank, posted record third-quarter results as net interest margin expanded and both loans and deposits advanced at …

First Resource Bank Sets Records as Margin Climbs and Assets Top $700 Million Read More

CubeSmart
Finance

CubeSmart Navigates Market Shifts With Stable Third-Quarter Results

November 7, 2025November 5, 2025 - by Timothy Alexander

MALVERN, PA — CubeSmart (NYSE: CUBE) reported steady third-quarter 2025 results that reflected both resilience and recalibration across its national self-storage portfolio. The Malvern-based real estate investment trust (REIT) posted …

CubeSmart Navigates Market Shifts With Stable Third-Quarter Results Read More
Omega Flex
Finance

Omega Flex Reports Lower Q3 Sales and Profit Amid Housing Market Headwinds

November 7, 2025November 4, 2025 - by Timothy Alexander

EXTON, PA — Omega Flex, Inc. (NASDAQ: OFLX) reported a decline in third-quarter and year-to-date results for 2025, citing persistent weakness in the residential housing market and higher construction costs …

Omega Flex Reports Lower Q3 Sales and Profit Amid Housing Market Headwinds Read More
Trinseo
Finance

Trinseo to Reveal Q3 2025 Results Amid Focus on Sustainable Material Growth

November 6, 2025November 3, 2025 - by Timothy Alexander

WAYNE, PA — Trinseo (NYSE: TSE), a global specialty materials solutions provider, announced plans to host a conference call to discuss its third-quarter 2025 financial results on Friday, November 7, …

Trinseo to Reveal Q3 2025 Results Amid Focus on Sustainable Material Growth Read More

Posts pagination

Previous 1 … 9 10 11 … 21 Next

Trending News

  • 401(k) Participation Hits Record High as Savings Rates Rise

  • Schuylkill Township: Where Valley Forge’s Story Still Lives

  • Education Department Shifts Programs to HHS, DOJ

  • HHS Unveils $708 Million Behavioral Health Funding Push

  • VA Launches Foreclosure Relief Program for At-Risk Veterans

Subscribe for Updates

Follow Us

  • Facebook
  • X
  • LinkedIn
  • Google
  • RSS Feed

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

Foreclosure

VA Launches Foreclosure Relief Program for At-Risk Veterans

19 hours agoJune 20, 2026

Thomas Coleman

Daycare Employee Charged After Child Assault Allegation

June 20, 2026June 20, 2026

Police News

Teen Suffers Serious Eye Injury in BB Gun Shooting

June 19, 2026June 19, 2026

Copyright © 2026 MyChesCo.